th On behalf of the organizing committee of the 13 International Conference on Biomedical Engineering, I extend our w- mest welcome to you. This series of conference began in 1983 and is jointly organized by the YLL School of Medicine and Faculty of Engineering of the National University of Singapore and the Biomedical Engineering Society (Singapore). First of all, I want to thank Mr Lim Chuan Poh, Chairman A*STAR who kindly agreed to be our Guest of Honour to give th the Opening Address amidst his busy schedule. I am delighted to report that the 13 ICBME has more than 600 participants from 40 countries. We have received very high quality papers and inevitably we had to turndown some papers. We have invited very prominent speakers and each one is an authority in their field of expertise. I am grateful to each one of them for setting aside their valuable time to participate in this conference. For the first time, the Biomedical Engineering Society (USA) will be sponsoring two symposia, ie “Drug Delivery S- tems” and “Systems Biology and Computational Bioengineering”. I am thankful to Prof Tom Skalak for his leadership in this initiative. I would also like to acknowledge the contribution of Prof Takami Yamaguchi for organizing the NUS-Tohoku’s Global COE workshop within this conference. Thanks also to Prof Fritz Bodem for organizing the symposium, “Space Flight Bioengineering”. This year’s conference proceedings will be published by Springer as an IFMBE Proceedings Series.

th On behalf of the organizing committee of the 13 International Conference on Biomedical Engineering, I extend our w- mest welcome to you. This series of conference began in 1983 and is jointly organized by the YLL School of Medicine and Faculty of Engineering of the National University of Singapore and the Biomedical Engineering Society (Singapore). First of all, I want to thank Mr Lim Chuan Poh, Chairman A*STAR who kindly agreed to be our Guest of Honour to give th the Opening Address amidst his busy schedule. I am delighted to report that the 13 ICBME has more than 600 participants from 40 countries. We have received very high quality papers and inevitably we had to turndown some papers. We have invited very prominent speakers and each one is an authority in their field of expertise. I am grateful to each one of them for setting aside their valuable time to participate in this conference. For the first time, the Biomedical Engineering Society (USA) will be sponsoring two symposia, ie “Drug Delivery S- tems” and “Systems Biology and Computational Bioengineering”. I am thankful to Prof Tom Skalak for his leadership in this initiative. I would also like to acknowledge the contribution of Prof Takami Yamaguchi for organizing the NUS-Tohoku’s Global COE workshop within this conference. Thanks also to Prof Fritz Bodem for organizing the symposium, “Space Flight Bioengineering”. This year’s conference proceedings will be published by Springer as an IFMBE Proceedings Series.

This book presents the proceedings of the 13th International Conference on Electrical Bioimpedance, ICEBI 2007, combined with the 8th Conference on Electrical Impedance Tomography, held at the Graz University of Technology in Graz, Austria, in August 2007.

This book constitutes extended and revised versions of the selected papers from the 13th International Joint Conference on Biomedical Engineering Systems and Technologies, BIOSTEC 2020, held in Valletta, Malta, in February 2020. The 29 revised and extended full papers presented were carefully reviewed and selected from a total of 363 submissions. The papers are organized in topical sections on biomedical electronics and devices; bioimaging; bioinformatics models, methods and algorithms; bio-inspired systems and signal processing; health informatic

July 24-25, 2017 Rome, Italy Key Topics : Pharmaceutical Nanotechnology, Novel Drug Delivery Technology, Nanomedicine and Drug Delivery, Nanotechnology for Pediatric Medicine, Nanotechnology in Preclinical and Clinical Development, Regulatory Guidance for Pharmaceutical Nanotechnology, Nanotechnology for Targeted Drug Delivery, Future Aspects of Pharmaceutical Nanotechnology, Recent Advances in Nanotechnology, Major Challenges in Nanotechnology, Pharmaceutical Companies and Markets, Business Opportunities in Nanotechnology, Nano Pharmaceuticals, Nanomedicines and Biomedical Applications,